$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
Oncology
Oncology
Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News
瑞格菲尼的治疗效果好吗?
2025-10-19 11:44:20
Check Details
瑞格菲尼主要可以治疗什么病症?
2025-10-19 11:44:20
Check Details
瑞格菲尼用量是多少呢?
2025-10-19 11:44:20
Check Details
瑞格菲尼三大获批适应症
2025-10-19 11:44:20
Check Details
瑞格菲尼治疗肝癌效果怎样?
2025-10-19 11:44:20
Check Details
瑞格菲尼可以治疗什么病症?
2025-10-19 11:44:20
Check Details
瑞格菲尼使用量是多少呢?
2025-10-19 11:44:20
Check Details
瑞格菲尼每日的推荐用量是多少?
2025-10-19 11:44:20
Check Details
瑞戈非尼疗效怎样呢?
2025-10-19 11:44:20
Check Details
瑞戈非尼国内什么时候上市呢?
2025-10-19 11:44:20
Check Details
瑞戈非尼国内怎样才买的到呢?
2025-10-19 11:44:20
Check Details
瑞戈非尼国内上市日期
2025-10-19 11:44:20
Check Details
1
2
...
2773
2774
2775
2776
2777
2778
2779
...
4153
4154
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Global Breakthrough: Pralsetinib - Precision Medicine for RET Mutation-Driven Cancers
2
Elacestrant: Precision Therapy for ESR1-Mutant Resistant HR+/HER2- Advanced Breast Cancer
3
Selpercatinib Complete Medication Guide: Indications, Dosage and Safety Information for RET Inhibitor
4
Complete Guide to Dosage and Dose Adjustment of Entrectinib
5
Comprehensive Analysis of Bleeding Risk with Tepotinib in MET-Mutated Non-Small Cell Lung Cancer
6
Lomustine vs Temozolomide: Comprehensive Comparison of Efficacy and Safety in Glioma Treatment
7
Tepotinib and Osimertinib: Current Status and Clinical Positioning of Combination Therapy in Non-Small Cell Lung Cancer
8
Tumor Shrinkage Effect and Core Therapeutic Value of Pazopanib
9
Tabrecta (Capmatinib): A Targeted Therapy for METex14-Mutated NSCLC
10
Pazopanib Shows Promise as Second-Line Therapy for Aggressive Skin Cancer
11
Managing Immunotherapy-Related Adverse Events of Tarlatamab-Imdelltra: A Guide to Dual-Specific T Cell Engager Safety
12
Almonertinib Safety Guide: Managing Adverse Reactions in NSCLC Treatment with a 3rd-Gen EGFR TKI